
Montserrat Alvaro Lozano
Jefe de Grupo
Research group
Last Publications
- Staubach P, Alvaro-Lozano M, Sekerel BE, Maurer M, Ben-Shoshan M, Porter M, Hua E, Ji Y, Burciu A, Savelieva M, Severin T, Drollmann A and Bienczak A Ligelizumab in adolescents with chronic spontaneous urticaria: Results of a dedicated phase 2b randomized clinical trial supported with pharmacometric analysis PEDIATRIC ALLERGY AND IMMUNOLOGY . 34(7): .
- Sahiner, UM, Giovannini, M, Escribese, MM, Paoletti, G, Heffler, E, Alvaro-Lozano M, Barber, D, Canonica, GW and Pfaar, O Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation Journal of Personalized Medicine . 13(5): .
- Arasi S, Nurmatov U, Dunn-Galvin A, Roberts G, Turner PJ, Shinder SB, Gupta R, Eigenmann P, Nowak-Wegrzyn A, Ansotegui IJ, Rivas MF, Petrou S, Tanno LK, Vazquez-Ortiz M, Vickery B, Wong G, Alvaro-Lozano M, Asaria M, Begin P, Bozzola M, Boyle R, Brough H, Cardona V, Chinthrajah RS, Cianferoni A, Deschildre A, Fleischer D, Gazzani F, Gerdts J, Giannetti M, Greenhawt M, Guzmán MA, Hossny E, Kauppi P, Jones C, Lucidi F, Monge Ortega OP, Munblit D, Muraro A, Pajno G, Podestà M, Rodriguez Del Rio P, Said M, Santos A, Shaker M, Szajewska H, Venter C, Warren C, Winders T, Ebisawa M and Fiocchi A WAO consensus on DEfinition of Food Allergy SEverity (DEFASE). World Allergy Organization Journal . 16(3): 100753-100753.
Projects
- Project name:
- Genetics of Food Allergy Barcelona Montserrat Alvaro
- Leader
- Montserrat Alvaro Lozano
- Funding entities:
- Max Delbrück Centrum für Molekulare medizin Berlin-Buch
- Code
- PCP00297
- Starting - finishing date:
- 2021 - 2023
- Project name:
- Desensibilizado versus arreactivo persistente: Análisis a largo plazo de la eficacia de la inmunoterapia oral específica a alimentos en niños con alergia a leche de vaca y huevo
- Leader
- Montserrat Alvaro Lozano
- Funding entities:
- Sociedad Española de Inmunología Clínica, Alergia y Asma Pediátrica
- Code
- PCP00240
- Starting - finishing date:
- 2018 - 2023